MIR3150BHG

Across TCGA pan-cancer cohorts, MIR3150BHG RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR3150BHG data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR3150BHG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3150BHG expression acts as an unfavorable survival marker, although some lineages such as CESC and LAML show a favorable association.

UVM, OV, and LIHC are the cancer types where MIR3150BHG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	II,III,IV	0.319	0.675	.004	58	view →
OV	OS	Quartile	IV	0.420	0.878	.002	46	view →
LIHC	OS	Tertile	All	0.586	0.778	.001	36	view →
LGG	DFS	Quartile	All	0.318	0.498	<.001	31	view →
CESC	OS	Quartile	All	0.950	0.819	.007	30	view →
LAML	DFS	Median	All	0.482	0.244	.002	18	view →
MESO	DFS	Median	All	0.193	0.597	.003	18	view →
UCEC	DFS	Median	All	0.578	0.706	.006	14	view →
BRCA	OS	Median	IV	0.185	0.569	.012	9	view →
SKCM	OS	Quartile	IV	0.133	0.613	.017	9	view →
ESCA	DFS	Median	All	0.423	0.571	.023	7	view →
CHOL	DFS	Quartile	All	0.796	0.309	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MIR3150BHG–UVM (DFS)

Open the UVM breakdown →